LCK and asthma: Additionally, uPAR overexpression universally caused changes in the expression of genes related to cellular proliferation (BRICD5) and T‐cell/B‐cell signaling (LCK/LIME1) and importantly asthma via the IL33 receptor (IL1RL1), now a target for new asthma drugs.